|
GB9414139D0
(en)
|
1994-07-13 |
1994-08-31 |
Smithkline Beecham Plc |
Novel compounds
|
|
AU703203B2
(en)
|
1996-01-30 |
1999-03-18 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
HUP0100156A3
(en)
|
1998-02-25 |
2002-12-28 |
Genetics Inst Inc Cambridge |
Indole derivatives as inhibitors of phospholipase a2 and use of them for producing pharmaceutical compositions
|
|
US6316503B1
(en)
|
1999-03-15 |
2001-11-13 |
Tularik Inc. |
LXR modulators
|
|
JP2004500332A
(ja)
|
1999-07-08 |
2004-01-08 |
テュラリク インコーポレイテッド |
Ｈｄｌコレステロール値を上昇させる組成物および方法
|
|
ATE310728T1
(de)
|
2000-05-11 |
2005-12-15 |
Bristol Myers Squibb Co |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
|
WO2002020463A2
(en)
|
2000-09-05 |
2002-03-14 |
Tularik Inc. |
Fxr modulators
|
|
WO2002046164A1
(en)
|
2000-12-07 |
2002-06-13 |
Astrazeneca Ab |
Therapeutic compounds
|
|
ES2284817T3
(es)
|
2001-01-26 |
2007-11-16 |
Chugai Seiyaku Kabushiki Kaisha |
Procedimientos para el tratamiento de enfermedades con inhibidores de la malonil coa descarboxilasa.
|
|
WO2003041641A2
(en)
|
2001-11-09 |
2003-05-22 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
|
US20050171084A1
(en)
|
2002-03-27 |
2005-08-04 |
Cairns William J. |
Methods of treatment with lxr modulators
|
|
AU2003227689A1
(en)
|
2002-04-29 |
2003-11-17 |
Novartis Ag |
Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha)
|
|
US20060189693A1
(en)
|
2003-07-22 |
2006-08-24 |
Barone Frank C |
Methods of treatment with lxr agonists
|
|
JP2007500158A
(ja)
|
2003-07-28 |
2007-01-11 |
グラクソ グループ リミテッド |
Ｌｘｒアゴニストを用いる炎症性腸疾患の治療方法
|
|
WO2005055998A1
(en)
|
2003-12-04 |
2005-06-23 |
Smithkline Beecham Corporation |
Methods of treatment with lxr agonists
|
|
WO2006091862A2
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Cytokine inhibitors and their use in therapy
|
|
WO2007055374A1
(ja)
|
2005-11-14 |
2007-05-18 |
Mitsubishi Tanabe Pharma Corporation |
骨粗鬆症治療剤
|
|
WO2007058990A2
(en)
|
2005-11-14 |
2007-05-24 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
|
AR059826A1
(es)
|
2006-03-13 |
2008-04-30 |
Univ California |
Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
|
|
CA2691214A1
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
TW200812962A
(en)
|
2006-07-12 |
2008-03-16 |
Astrazeneca Ab |
New compounds I/418
|
|
US20090291983A1
(en)
|
2006-07-12 |
2009-11-26 |
Astrazeneca Ab |
3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents
|
|
CL2007002670A1
(es)
|
2006-09-15 |
2008-05-16 |
Celgene Corp Soc Organizada Ba |
Compuestos derivados de n-metilaminometil-isoindolina; composicion farmaceutica; forma de dosificacion, util para tratar o prevenir enfermedades tales como cancer, dolor, trastorno pulmonar, trastorno del snc y aterosclerosis.
|
|
JP4846769B2
(ja)
|
2007-07-30 |
2011-12-28 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP4834699B2
(ja)
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
WO2011115892A1
(en)
|
2010-03-15 |
2011-09-22 |
Griffin Patrick R |
Modulators of the retinoic acid receptor-related orphan receptors
|
|
WO2012028100A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
|
WO2012027965A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
|
WO2012100732A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
|
|
WO2012100734A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Compounds useful as retinoid-related orphan receptor gamma modulators
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
|
WO2013029338A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel compounds
|
|
WO2013100027A1
(ja)
|
2011-12-28 |
2013-07-04 |
武田薬品工業株式会社 |
複素環化合物
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
EP2844247A4
(en)
|
2012-04-20 |
2015-11-25 |
Anderson Gaweco |
ROR MODULATORS AND ITS USES
|
|
EP2844259A4
(en)
|
2012-04-30 |
2015-11-11 |
Anderson Gaweco |
MMR MODULATORS AND USES THEREOF
|
|
EP2844260A4
(en)
|
2012-04-30 |
2016-06-29 |
Anderson Gaweco |
ROR MODULATORS AND ITS USES
|
|
WO2013171729A2
(en)
|
2013-01-08 |
2013-11-21 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl amide compounds as rorgamat modulator
|
|
WO2014125426A1
(en)
|
2013-02-15 |
2014-08-21 |
Aurigene Discovery Technologies Limited |
Trisubstituted heterocyclic derivatives as ror gamma modulators
|
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
WO2014179564A1
(en)
|
2013-05-01 |
2014-11-06 |
Vitae Pharmaceuticals, Inc. |
Thiazalopyrrolidine inhibitors of ror-gamma
|
|
JP6427491B2
(ja)
|
2013-07-03 |
2018-11-21 |
武田薬品工業株式会社 |
複素環化合物
|
|
EP3018123B1
(en)
|
2013-07-03 |
2023-05-10 |
Takeda Pharmaceutical Company Limited |
Amide compound
|
|
EP3027616B1
(en)
|
2013-07-30 |
2018-01-10 |
Boehringer Ingelheim International GmbH |
Azaindole compounds as modulators of rorc
|
|
EP3041821B1
(en)
|
2013-09-05 |
2018-05-30 |
Boehringer Ingelheim International GmbH |
Bicylic compounds as modulators of rorgamma
|
|
WO2015082533A1
(en)
|
2013-12-05 |
2015-06-11 |
Lead Pharma Cel Models Ip B.V. |
Ror gamma (rory) modulators
|
|
WO2015083130A1
(en)
|
2013-12-06 |
2015-06-11 |
Aurigene Discovery Technologies Limited |
Fused pyridine and pyrimidine derivatives as ror gamma modulators
|
|
WO2015101928A1
(en)
|
2013-12-31 |
2015-07-09 |
Aurigene Discovery Technologies Limited |
Fused thiophene and thiazole derivatives as ror gamma modulators
|
|
AU2015210833B2
(en)
|
2014-02-03 |
2019-01-03 |
Vitae Pharmaceuticals, Llc |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
|
JPWO2015129853A1
(ja)
|
2014-02-27 |
2017-03-30 |
東レ株式会社 |
環状アミン誘導体及びその医薬用途
|
|
WO2015145371A1
(en)
|
2014-03-27 |
2015-10-01 |
Piramal Enterprises Limited |
Ror-gamma modulators and uses thereof
|
|
NZ723530A
(en)
|
2014-04-14 |
2023-05-26 |
Boehringer Ingelheim Int |
Compounds as modulators of ror gamma
|
|
SG11201607518RA
(en)
|
2014-04-16 |
2016-10-28 |
Glenmark Pharmaceuticals Sa |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
|
MA40060A
(fr)
|
2014-07-01 |
2016-01-07 |
Takeda Pharmaceuticals Co |
Composés hétérocycliques et leur utilisation en tant qu'inhibiteurs gamma-t du récepteur orphelin apparenté aux récepteurs des rétinoïdes (ror) )
|
|
CR20170077A
(es)
|
2014-08-04 |
2017-06-26 |
Nuevolution As |
Derivados de heterociclilo opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias
|
|
MA40759A
(fr)
|
2014-09-26 |
2017-08-01 |
Pfizer |
Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
|
|
JP6564029B2
(ja)
|
2014-10-14 |
2019-08-21 |
ヴァイティー ファーマシューティカルズ，エルエルシー |
Ｒｏｒ−ガンマのジヒドロピロロピリジン阻害剤
|
|
US9663515B2
(en)
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
|
US9845308B2
(en)
*
|
2014-11-05 |
2017-12-19 |
Vitae Pharmaceuticals, Inc. |
Isoindoline inhibitors of ROR-gamma
|
|
JP2017538676A
(ja)
|
2014-11-05 |
2017-12-28 |
ザ ユニバーシティ オブ カンザス |
ミトコンドリア透過性遷移孔（ｍｔＰＴＰ）の小分子阻害剤
|
|
WO2016176399A1
(en)
|
2015-04-28 |
2016-11-03 |
Stc.Unm |
Compositions and methods for treatment of pulmonary hypertension
|
|
SI3294713T1
(sl)
|
2015-05-15 |
2021-08-31 |
Aurigene Discovery Technologies Limited, |
Nadomeščene spojine tetrahidrokinolinona kot ROR gama modulatorji
|
|
EP3101009A1
(en)
|
2015-06-05 |
2016-12-07 |
Lead Pharma Cel Models IP B.V. |
Ror gamma (rory) modulators
|
|
EP3101005A1
(en)
|
2015-06-05 |
2016-12-07 |
Lead Pharma Cel Models IP B.V. |
Ror gamma (rory) modulators
|
|
EP3101006A1
(en)
|
2015-06-05 |
2016-12-07 |
Lead Pharma Cel Models IP B.V. |
Ror gamma (rory) modulators
|
|
EP3101007A1
(en)
|
2015-06-05 |
2016-12-07 |
Lead Pharma Cel Models IP B.V. |
Ror gamma (rory) modulators
|
|
EP3101008A1
(en)
|
2015-06-05 |
2016-12-07 |
Lead Pharma Cel Models IP B.V. |
Ror gamma (rory) modulators
|
|
WO2017010399A1
(ja)
|
2015-07-10 |
2017-01-19 |
塩野義製薬株式会社 |
ＲＯＲγｔ阻害作用を有する化合物およびそれらを含有する医薬組成物
|
|
DK3331876T3
(da)
|
2015-08-05 |
2021-01-11 |
Vitae Pharmaceuticals Llc |
Modulators of ror-gamma
|
|
EP3356366B1
(en)
|
2015-10-01 |
2019-08-28 |
Boehringer Ingelheim International GmbH |
Pteridine derivatives as modulators of ror gamma
|
|
CN109071516B
(zh)
|
2015-12-15 |
2021-08-31 |
阿斯利康(瑞典)有限公司 |
新颖的化合物
|